Triplet Puzzle: Homologies of receptor heteromers

Journal of Molecular Neuroscience

Volumn 41, Issue 2, 2010, Pages 294-303

  Tarakanov, Alexander O ^a   Fuxe, Kjell G ^b  

^a ST PETERSBURG INSTITUTE FOR INFORMATICS AND AUTOMATION   (Russian Federation)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Receptor receptor interactions; Triplet homology

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ANGIOTENSIN 1 RECEPTOR; BRADYKININ B2 RECEPTOR; CANNABINOID 1 RECEPTOR; CHOLECYSTOKININ RECEPTOR; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 5 RECEPTOR; GAMMA INTERFERON RECEPTOR 1; GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 2; GLUTAMATE RECEPTOR 5; MELATONIN 1 RECEPTOR; NEUROTENSIN RECEPTOR; OPIATE RECEPTOR; OREXIN 1 RECEPTOR; PURINERGIC P2Y1 RECEPTOR; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 2A RECEPTOR; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 5; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6;

ARTICLE; DIMERIZATION; HUMAN; INNATE IMMUNITY; MATHEMATICAL ANALYSIS; PROTEIN ANALYSIS; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; STRUCTURAL HOMOLOGY;

AMINO ACID SEQUENCE; MEMBRANE PROTEINS; MODELS, MOLECULAR; MODELS, THEORETICAL; MOLECULAR SEQUENCE DATA; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY;

EID: 77951620820     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-009-9313-5     Document Type: Article

References (86)

1. S AbdAlla H Lother A el Massiery U Quitterer 2001 Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness Nat Med 7 1003 1009 10.1038/nm0901-1003 1:CAS:528: DC%2BD3MXmvFOlsr4%3D 11533702 (Pubitemid 32937379)
2. L Adamian R Jackups A Binkowski J Liang 2003 Higher-order interhelical spatial interactions in membrane proteins J Mol Bio 327 251 272 10.1016/S0022-2836(03)00041-X 1:CAS:528:DC%2BD3sXhsVCnsr0%3D (Pubitemid 36293317)
3. LF Agnati S Ferre C Lluis R Franco K Fuxe 2003 Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurone Pharmacol Rev 55 509 550 10.1124/pr.55.3.2 1:CAS:528:DC%2BD3sXnsVynurg%3D 12869660 (Pubitemid 37013214)
4. LF Agnati AO Tarakanov S Ferré K Fuxe D Guidolin 2005 Receptor-receptor interactions, receptor mosaics, and basic principles of molecular network organization: possible implications for drug development J Mol Neurosci 26 2-3 193 208 10.1385/JMN:26:2-3:193 1:CAS:528:DC%2BD2MXmtl2ksrY%3D 16012193 (Pubitemid 41389412)
5. S Akira S Uematsu O Takeuchi 2006 Pathogen recognition and innate immunity Cell 124 4 783 801 10.1016/j.cell.2006.02.015 1:CAS:528: DC%2BD28Xit1Kltb8%3D 16497588 (Pubitemid 43261452)
6. MA Ayoub A Levoye P Delagrange R Jockers 2004 Preferential formation of MT1/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers Mol Pharmacol 66 312 321 10.1124/mol.104.000398 1:CAS:528:DC%2BD2cXmtVyksr8%3D 15266022 (Pubitemid 38989488)
7. J Baardsnes J Jelokhani-Niaraki LH Kondejewski, et al. 2001 Antifreeze protein from shorthorn sculpin: identification of the ice-binding surface Protein Sci 10 12 2566 2576 10.1110/ps.ps.26501 1:CAS:528:DC%2BD3MXovVyru7c%3D 11714925 (Pubitemid 33094455)
8. JG Baker SJ Hill 2007 Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimates Trends Pharmacol Sci 28 374 381 10.1016/j.tips.2007.06.011 1:CAS:528:DC%2BD2sXotlWltLo%3D 17629959 (Pubitemid 47087964)
9. JK Bell I Botos PR Hall, et al. 2005 The molecular structure of the Toll-like receptor 3 ligand-binding domain Proc Natl Acad Sci U S A 102 31 10976 10980 10.1073/pnas.0505077102 1:CAS:528:DC%2BD2MXnvVWjur4%3D 16043704 (Pubitemid 41105978)
10. M Block L Zecca JS Hong 2007 Microglia-mediated neurotoxicity: uncovering the molecular mechanisms Nat Rev Neurosci 8 1 57 69 10.1038/nrn2038 1:CAS:528:DC%2BD28XhtlemtL7M 17180163 (Pubitemid 46011999)
11. M Canals D Marcellino F Fanelli, et al. 2003 Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer J Biol Chem 278 47 46741 46749 10.1074/jbc.M306451200 1:CAS:528:DC%2BD3sXovFKks7k%3D 12933819 (Pubitemid 37452253)
12. P Carriba O Ortiz K Patkar, et al. 2007 Striatal adenosine A2A and cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids Neuropsychopharmacol 32 11 2249 2259 10.1038/sj.npp.1301375 1:CAS:528:DC%2BD2sXhtFOjtLzN (Pubitemid 47587686)
13. F Ciruela J Burqueño V Casadó, et al. 2004 Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors Anal Chem 76 18 5354 5363 10.1021/ac049295f 1:CAS:528:DC%2BD2cXmtFOntbs%3D 15362892 (Pubitemid 39249416)
14. F Ciruela V Casadó RJ Rodrigues, et al. 2006 Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers J Neurosci 26 7 2080 2087 10.1523/JNEUROSCI.3574-05.2006 1:CAS:528:DC%2BD28XitVansbo%3D 16481441 (Pubitemid 43295859)
15. S Dasgupta XM Li A Jansson, et al. 1996 Regulation of dopamine D2 receptor affinity by cholecystokinin octapeptide in fibroblast cells cotransfected with human CCKB and D2L receptor cDNAs Mol Brain Res 36 2 292 299 10.1016/0169-328X(95)00283-X 1:CAS:528:DyaK28XhvVKrtbk%3D 8965650 (Pubitemid 126349902)
16. Z Díaz-Cabiale K Fuxe JA Narváez, et al. 2002 Neurotensin-induced modulation of dopamine D2 receptors and their function in rat striatum: counteraction by a NTR1-like receptor antagonist NeuroReport 13 6 763 766 10.1097/00001756-200205070-00006 11997683
17. CA Doyle JL Strominger 1987 Interaction between CD4 and class II MHC molecules mediates cell adhesion Nature 330 256 259 10.1038/330256a0 1:CAS:528:DyaL1cXjtlyjtg%3D%3D 2823150 (Pubitemid 18006419)
18. L El-Asmar JY Springael S Ballet EU Andrieu G Vassart M Parmentier 2005 Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers Mol Pharmacol 67 460 469 10.1124/mol.104.003624 1:CAS:528:DC%2BD2MXhtVWrsLk%3D 15509716 (Pubitemid 40216739)
19. J Ellis JD Pediani M Canals S Milasta G Milligan 2006 Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function J Biol Chem 281 50 38812 38824 10.1074/jbc.M602494200 1:CAS:528:DC%2BD28Xht12msrvM 17015451 (Pubitemid 46042008)
20. F Fanelli 2007 Dimerization of the lutropin receptor: insights from computational modeling Mol Cell Endocrinol 260-262 59 64 10.1016/j.mce.2005.12. 054 17052834 (Pubitemid 44792332)
21. DU Fereiro AM Walczak EA Komives PG Wolynes 2008 The energy landscapes of repeat-containing proteins: topology, cooperativity, and the folding funnels of one-domensional architectures PLoS Compt Biol 4 5 e1000070 10.1371/journal. pcbi.1000070 (Pubitemid 351811550)
22. S Ferré M Karcz-Kubicha BT Hope, et al. 2002 Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function Proc Natl Acad Sci U S A 99 18 11940 11945 10.1073/pnas.172393799 12189203 (Pubitemid 34994503)
23. R Franco V Casadó A Cortéz, et al. 2008 Novel pharmacological targets based on receptor heteromers Brain Res Rev 58 2 475 482 10.1016/j.brainresrev.2008.06.002 1:CAS:528:DC%2BD1cXhtVagt7jK 18620000
24. K Fuxe S Ferré M Zoli LF Agnati 1998 Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia Brain Res Rev 26 258 273 10.1016/S0165-0173(97)00049-0 1:CAS:528:DyaK1cXjs1art7Y%3D 9651540 (Pubitemid 28318081)
25. K Fuxe M Canals M Torvinen, et al. 2007 Intramembrane receptor-receptor interactions: a novel principle in molecular medicine J Neural Transm 114 1 49 75 10.1007/s00702-006-0589-0 1:CAS:528:DC%2BD28XhtlCksbnE 17066251 (Pubitemid 46018675)
26. K Fuxe D Marcellino A Rivera, et al. 2008 Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology Brain Res Rev 58 2 415 452 10.1016/j.brainresrev.2007.11.007 1:CAS:528:DC%2BD1cXhtVagt7jP 18222544
27. KG Fuxe AO Tarakanov LB Goncharova LF Agnati 2008 A new road to neuroinflammation in Parkinson's disease? Brain Res Rev 58 2 453 458 10.1016/j.brainresrev.2008.04.003 1:CAS:528:DC%2BD1cXhtVagt7jI 18457883
28. J Gandia J Galino OB Amaral, et al. 2008 Detection of higher-order G protein-coupled receptor oligomers by a combined BRET-BiFC technique FEBS Lett 582 20 2979 2984 10.1016/j.febslet.2008.07.045 1:CAS:528:DC%2BD1cXhtVensL7I 18675812
29. GF Gao J Tormo UC Gerth, et al. 1997 Crystal structure of the complex between human CD8alpha and HLA-A2 Nature 387 6633 630 634 10.1038/42523 1:CAS:528:DyaK2sXktFCitbo%3D 9177355 (Pubitemid 27248771)
30. NJ Gay M Gangloff AN Weber 2006 Toll-like receptors as molecular switches Nat Rev Immunol 6 9 693 698 10.1038/nri1916 1:CAS:528:DC%2BD28Xos12gtrc%3D 16917510 (Pubitemid 44298218)
31. A Gilchrist 2007 Modulating G-protein-coupled receptors: from traditional pharmacology to allosterics Trends Pharmacol Sci 28 431 437 10.1016/j.tips.2007.06.012 1:CAS:528:DC%2BD2sXotlWltb8%3D 17644194 (Pubitemid 47087973)
32. S Ginés J Hillion M Torvinen, et al. 2000 Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes Proc Natl Acad Sci U S A 97 15 8606 8611 10.1073/pnas.150241097 10890919 (Pubitemid 30639720)
33. I Gomes BA Jordan A Gupta N Trapaidze V Nagy LA Devi 2000 Heterodimerization of mu and delta opioid receptors: a role in opiate synergy J Neurosci 20 RC110 1:STN:280:DC%2BD3M7itFGmsw%3D%3D 11069979
34. LB Goncharova AO Tarakanov 2008 Carbon nanotubes in medicinal biochips Curr Med Chem 15 3 210 218 10.2174/092986708784535009 1:CAS:528: DC%2BD1cXnsVyisrk%3D 18288981 (Pubitemid 351997799)
35. LB Goncharova AO Tarakanov 2008 Why chemokines are cytokines while their receptors are not cytokine ones? Curr Med Chem 15 13 1297 1304 10.2174/092986708784535009 1:CAS:528:DC%2BD1cXnsVyhsrs%3D 18537609 (Pubitemid 351997799)
36. J Gonzalez-Maeso RL Ang T Yuen, et al. 2008 Identification of a serotonin/glutamate receptor complex implicated in psychosis Nature 452 93 97 10.1038/nature06612 1:CAS:528:DC%2BD1cXivFynu7w%3D 18297054 (Pubitemid 351355090)
37. NM Goodey SJ Benkovic 2008 Allosteric regulation and catalysis emerge via a common route Nat Chem Biol 4 474 482 10.1038/nchembio.98 1:CAS:528: DC%2BD1cXoslClsb8%3D 18641628 (Pubitemid 352019763)
38. W Guo L Shi M Filizola H Weinstein JA Javitch 2005 From the cover: crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation Proc Natl Acad Sci U S A 102 48 17495 17500 10.1073/pnas.0508950102 1:CAS:528:DC%2BD2MXhtlSqtb3N 16301531 (Pubitemid 41740894)
39. W Guo E Urizar M Kravilkova, et al. 2008 Dopamine D2 receptors form higher order oligomers at physiological expression levels EMBO J 27 17 2293 2304 10.1038/emboj.2008.153 1:CAS:528:DC%2BD1cXhtVGkt7jI 18668123
40. VV Gurevich EV Gurevich 2008 How and why do GPCRs dimerize? Trends Pharmacol Sci 29 234 240 10.1016/j.tips.2008.02.004 1:CAS:528: DC%2BD1cXlslWqurc%3D 18384890
41. A Guyon JL Nahon 2007 Multiple actions of the chemokine stromal cell-derived factor-1a on neuronal activity J Mol Endocrinol 38 365 376 10.1677/JME-06-0013 1:CAS:528:DC%2BD2sXlsVWgurc%3D 17339399 (Pubitemid 46723252)
42. C Hague SE Lee Z Chen SC Prinster RA Hall KP Minneman 2006 Heterodimers of alpha1B- and alpha1D-adrenergic receptors form a single functional entity Mol Pharmacol 69 1 45 55 1:CAS:528:DC%2BD28XktlWhuw%3D%3D 16195468
43. J Hillion M Canals M Torvinen, et al. 2002 Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors J Biol Chem 277 18091 18097 10.1074/jbc.M107731200 1:CAS:528:DC%2BD38XktVCmsrc%3D 11872740 (Pubitemid 34967623)
44. DJ Hilton JG Zhang D Metcalf WS Alexander NA Nicola TA Wilson 1996 Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor Proc Natl Acad Sci U S A 96 497 501 10.1073/pnas.93.1.497 (Pubitemid 26038184)
45. M Hirono T Yoshioka S Konishi 2001 GABA(B) receptor activation enhances mGluR-mediated responses at cerebellar excitatory synapses Nat Neurosci 4 1207 1216 10.1038/nn764 1:CAS:528:DC%2BD3MXovVCqu74%3D 11704764 (Pubitemid 33135626)
46. MS Jin SE Kim JY Heo, et al. 2007 Crystal structure of the TL1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide Cell 130 1071 1082 10.1016/j.cell.2007.09.008 1:CAS:528:DC%2BD2sXhtFKnurvE 17889651 (Pubitemid 47410281)
47. BA Jordan LA Devi 1999 G-protein-coupled receptor heterodimerization modulates receptor function Nature 399 697 700 10.1038/21441 1:CAS:528:DyaK1MXkt1Snsbc%3D 10385123 (Pubitemid 29289066)
48. T Kamiya O Saitoh K Yoshioka H Nakata 2003 Oligomerization of adenosine A2A and dopamine D2 receptors in living cells Biochem Biophys Res Commun 306 2 544 549 10.1016/S0006-291X(03)00991-4 1:CAS:528:DC%2BD3sXksVyktLg%3D 12804599 (Pubitemid 36683109)
49. CS Kearn K Blake-Palmer E Daniel K Mackie M Glass 2005 Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? Mol Pharmacol 67 5 1697 1704 10.1124/mol.104.006882 1:CAS:528:DC%2BD2MXktFegt7c%3D 15710746 (Pubitemid 40594170)
50. T Kenakin 2007 Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors Trends Pharmacol Sci 28 407 415 10.1016/j.tips.2007.06.009 1:CAS:528:DC%2BD2sXotlWltLY%3D 17629960 (Pubitemid 47087972)
51. A Kohl HK Binz P Forrer MT Stumpp A Plückthun MG Grütter 2003 Designed to be stable: crystal structure of a consensus ankyrin repeat protein Proc Natl Acad Sci U S A 100 4 1700 1705 10.1073/pnas.0337680100 1:CAS:528:DC%2BD3sXhsFGktbg%3D 12566564 (Pubitemid 36254511)
52. R König Y Zhou D Elleder, et al. 2008 Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication Cell 135 49 60 10.1016/j.cell.2008.07.032 18854154
53. R Kuner G Köhr S Grünewald G Eisenhardt A Bach HC Kornau 1999 Role of heteromer formation in GABAB receptor function Science 283 74 77 10.1126/science.283.5398.74 1:CAS:528:DyaK1MXktFWhug%3D%3D 9872744 (Pubitemid 29044849)
54. SP Lee CH So AJ Rashid, et al. 2004 Dopamine D1 and D2 receptor co-activation generanks a novel phospholipase C-mediated calcium signal J Biol Chem 279 34 35671 35678 10.1074/jbc.M401923200 1:CAS:528:DC%2BD2cXmsl2hsb4%3D 15159403 (Pubitemid 39100570)
55. F Liu Q Wan ZB Pristupa XM Yu YT Wang HB Niznik 2000 Direct protein-protein coupling enables cross-talk between dopamine D5 and g-aminobutyric acid A receptors Nature 403 274 280 10.1038/35001232 1:CAS:528:DC%2BD3cXns1Cisw%3D%3D 10659839 (Pubitemid 30062376)
56. JF Lopez-Gimenez M Canals JD Pediani G Milligan 2007 The alpha1b-adrenoceptor exists as a higher-order oligomer: effective oligomerization is required for receptor maturation, surface delivery, and function Mol Pharmacol 71 4 1015 1029 10.1124/mol.106.033035 1:CAS:528:DC%2BD2sXkt1Ohurk%3D 17220353 (Pubitemid 46457006)
57. D Marcellino S Ferré V Casadó, et al. 2008 Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum J Biol Chem 283 26016 26025 10.1074/jbc.M710349200 1:CAS:528:DC%2BD1cXhtFSltLvF 18644790
58. D Marcellino P Carriba M Filip, et al. 2008 Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis Neuropharmac 54 5 815 823 10.1016/j.neuropharm.2007.12.011 1:CAS:528:DC%2BD1cXjs1Slurg%3D
59. FH Marshall KA Jones K Kaupmann B Bettler 2001 GABAB receptors-the first 7TM heterodimers Trends Pharmacol Sci 20 10 396 399 10.1016/S0165-6147(99)01383- 8
60. N Matsushima T Tanaka P Enkhbayar, et al. 2007 Comparative sequence analysis of leucine-rich repeats (LRRs) within vertebrate toll-like receptors BMC Genomics 8 124 145 10.1186/1471-2164-8-124 17517123 (Pubitemid 46995052)
61. G Milligan 2008 A day in the life of a G protein-coupled receptor: the contribution to function of G protein-coupled receptor dimerization Br J Pharmacol 153 S216 S229 10.1038/sj.bjp.0707490 1:CAS:528:DC%2BD1cXislSjtro%3D 17965750 (Pubitemid 351340980)
62. T Mizuno G Zhang H Takeuchi, et al. 2008 Interferon-γ directly induces neurotoxicity through a neuron specific, calcium-permeable complex of IFN-γ receptor and AMPA GluR1 receptor FASEB J 22 1797 1806 10.1096/fj.07-099499 1:CAS:528:DC%2BD1cXnsVKis7s%3D 18198214 (Pubitemid 351811457)
63. MF Moran CA Koch I Sadowski T Pawson 1988 Mutational analysis of a phosphotransfer motif essential for v-fps tyrosine kinase activity Oncogene 3 6 665 672 1:CAS:528:DyaL1MXit1Olurk%3D 2577868 (Pubitemid 19030377)
64. NCBI (2009) National center for biotechnology information ( http://www.ncbi.nlm.nih.gov ).
65. Y Percherancier A Berchiche I Slight, et al. 2005 Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers J Biol Chem 280 11 9895 9903 10.1074/jbc.M411151200 1:CAS:528:DC%2BD2MXit1erurg%3D 15632118 (Pubitemid 40395837)
66. M Pfeiffer S Kirscht R Stumm, et al. 2003 Heterodimerization of substance P and mu-opioid receptors regulates receptor trafficking and resensitization J Biol Chem 278 51 51630 51637 10.1074/jbc.M307095200 1:CAS:528: DC%2BD3sXpslOgs70%3D 14532289 (Pubitemid 38020408)
67. JP Pin R Neubig M Bouvier, et al. 2007 International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and Nomenclature of G protein-coupled receptor heteromultimers Pharmacol Rev 59 5 13 10.1124/pr.59.1.5 1:CAS:528:DC%2BD2sXkt1WmtLY%3D 17329545 (Pubitemid 46335687)
68. P Popoli A Pèzzola M Torvinen, et al. 2001 The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors Neuropsychopharmacol 25 4 505 513 10.1016/S0893-133X(01)00256-1 1:CAS:528:DC%2BD3MXms12msbc%3D (Pubitemid 32830955)
69. AJ Rashid CH So MM Kong, et al. 2007 D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum Proc Natl Acad Sci U S A 104 2 654 659 10.1073/pnas.0604049104 1:CAS:528:DC%2BD2sXovFKksg%3D%3D 17194762 (Pubitemid 46123080)
70. C Rios I Gomes LA Devi 2006 Mu opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis Br J Pharmacol 148 4 387 395 10.1038/sj.bjp.0706757 1:CAS:528:DC%2BD28XlsV2rsro%3D 16682964 (Pubitemid 43882074)
71. M Rocheville DC Lange U Kumar SC Patel YC Patel 2000 Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity Science 288 154 157 10.1126/science.288.5463.154 1:CAS:528:DC%2BD3cXisVGku7o%3D 10753124 (Pubitemid 30203051)
72. M Rocheville DC Lange U Kumar R Sasi SC Patel YC Patel 2000 Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers J Biol Chem 275 7862 7869 10.1074/jbc.275.11.7862 1:CAS:528:DC%2BD3cXitVyltr4%3D 10713101 (Pubitemid 30159693)
73. M Scarselli F Novi E Schallmach, et al. 2001 D2/D3 dopamine receptor heterodimers exhibit unique functional properties J Biol Chem 276 32 30308 303014 10.1074/jbc.M102297200 1:CAS:528:DC%2BD3MXmtFeht7c%3D 11373283 (Pubitemid 37385114)
74. S Suzuki LF Chuang P Yau RH Doi RY Chuang 2002 Interactions of opioid and chemokine receptors: oligomerization of mu, kappa, and delta with CCR5 on immune cells Exp Cell Res 280 2 192 200 10.1006/excr.2002.5638 1:CAS:528:DC%2BD38XotFGgs70%3D 12413885 (Pubitemid 35333761)
75. L Szidonya M Cserzo L Hunyady 2008 Dimerization and oligomerization of G-protein-coupled receptors: debated structures with established and emerging functions J Endocrinol 196 435 453 10.1677/JOE-07-0573 1:CAS:528: DC%2BD1cXkt1Cgtb0%3D 18310440 (Pubitemid 351425500)
76. A Tarakanov A Prokaev 2007 Identification of cellular automata by immunocomputing J Cell Autom 2 1 39 45
77. AO Tarakanov LB Goncharova 2009 Cell-cell nanotubes: Tunneling through several types of synapses Commun Integr Biol 2 4 359 361 1:CAS:528: DC%2BD1MXht1yqsr%2FE 19721891
78. AO Tarakanov KG Fuxe LF Agnati LB Goncharova 2009 Possible role of receptor heteromers in multiple sclerosis J Neural Transmis 116 989 994 10.1007/s00702-009-0197-x 1:CAS:528:DC%2BD1MXosVynt7c%3D
79. AB Tobin AJ Butcher KC Kong 2008 Location, location, location... site-specific GPCR phosphorylation offers a mechanism for cell-type-specific signalling Trends Pharmacol Sci 29 8 413 420 10.1016/j.tips.2008.05.006 1:CAS:528:DC%2BD1cXpsVCluro%3D 18606460
80. M Torvinen D Marcellino M Canals, et al. 2005 Adenosine A2A receptor and dopamine D3 receptor interactions: evidence of functional A2A/D3 heteromeric complexes Mol Pharmacol 67 2 400 407 10.1124/mol.104.003376 1:CAS:528: DC%2BD2MXhtVWrsL4%3D 15539641 (Pubitemid 40216732)
81. G von Euler 1991 Biochemical characterization of the intramembrane interaction between neurotensin and dopamine D2 receptors in the rat brain Brain Res 561 93 98 10.1016/0006-8993(91)90753-I
82. JH Wang R Meijers Y Xiong, et al. 2001 Crystal structure of the human CD4 N-terminal two-domain fragments complexed to a class II MHC molecule Proc Natl Acad Sci U S A 98 19 10799 10804 10.1073/pnas.191124098 1:CAS:528: DC%2BD3MXntVGmsLw%3D 11535811 (Pubitemid 32878700)
83. AS Woods S Ferré 2005 Amazing stability of the arginine-phosphate electrostatic interaction Proteome Res 4 1397 1402 10.1021/pr050077s 1:CAS:528:DC%2BD2MXlvVahsb0%3D (Pubitemid 41208697)
84. AS Woods D Marcellino SN Jackson, et al. 2008 How calmodulin interacts with the adenosine A2A and the dopamine D2 receptotrs J Proteome Res 7 8 3428 3434 10.1021/pr8001782 1:CAS:528:DC%2BD1cXnvFSqs7w%3D 18590318
85. Z Xie SP Lee BF O'Dowd SR George 1999 Serotonin 5-HT1B and 5-HT1D receptors from homodimers when expressed alone and heterodimers when coexpressed FEBS Lett 456 63 67 10.1016/S0014-5793(99)00918-7 1:CAS:528:DyaK1MXlsFSlu7c%3D 10452531 (Pubitemid 29339042)
86. K Yoshioka O Saitoh H Nakata 2001 Heteromeric association creates a P2Y-like adenosine receptor Proc Natl Acad Sci U S A 98 7617 7622 10.1073/pnas.121587098 1:CAS:528:DC%2BD3MXkslWlsLY%3D 11390975 (Pubitemid 32567997)